treprostinil 0.106 MG Inhalation Powder [Yutrepia]
RxNorm concept 2714676, branded drug (sbd). Prescribable name: Yutrepia 106 MCG Inhalation Powder.
- RxCUI
- 2714676
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2714676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Yutrepia 0.106 MG Inhalation Powder; Yutrepia 106 MCG (as treprostinil sodium) Inhalation Powder; Yutrepia 106 MCG Inhalation Powder
Related concepts
- treprostinil 0.106 MG (SCDC, consists of)
- treprostinil 0.106 MG [Yutrepia] (SBDC, consists of)
- Inhalation Powder (DF, has dose form)
- Yutrepia (BN, has ingredient)
- treprostinil 0.106 MG Inhalation Powder (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2714676 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2714676 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2714676. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.